Trial Profile
Effect of Sildenafil on the Microcirculatory Blood Flow and on the Endothelial Progenitor Cells in Patients With Systemic Sclerosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2016
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Raynaud's disease; Sclerosis
- Focus Pharmacodynamics
- 19 Dec 2013 New trial record
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.